Michael Carter
Director/Board Member chez ONCTERNAL THERAPEUTICS, INC.
Fortune : 33 318 $ au 31/03/2024
Profil
Michael G.
Carter is currently a Non-Executive Director at Artios Pharma Ltd.
and an Independent Director at Oncternal Therapeutics, Inc. He previously held positions as Non-Executive Chairman at Metris Therapeutics Ltd., Director at CancerVax Corp., Independent Director at Santarus, Inc., Non-Executive Director at Fulcrum Pharma Plc, Non-Executive Director at Micromet AG, Non-Executive Director at Oxagen Ltd., Non-Executive Director at Amgen Rockville, Inc., Non-Executive Director at OncoEthix SA, Director-Pharmaceutical Division at Roche Products Ltd., Director-International Medical & Marketing at Zeneca Pharmaceuticals, Member-Pharmaceutical Board at AstraZeneca, Inc., and Venture Partner at SV Health Investors LLP.
He is also an Advisor at Healthcare Royalty Management LLC.
Dr. Carter holds a doctorate from The University of Sheffield and an undergraduate degree from UCL School of Pharmacy.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/06/2023 | 3 702 ( 0,13% ) | 33 318 $ | 31/03/2024 |
Postes actifs de Michael Carter
| Sociétés | Poste | Début |
|---|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Director/Board Member | 07/06/2019 |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Director/Board Member | - |
Anciens postes connus de Michael Carter
| Sociétés | Poste | Fin |
|---|---|---|
Oxagen Ltd.
 Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Director/Board Member | 22/08/2017 |
OncoEthix SA
 OncoEthix SA Pharmaceuticals: MajorHealth Technology OncoEthix SA operates as a clinical stage biotechnology company which develops cancer drugs. Its products include OTX008, OTX015, and OTX009. The company was founded by Esteban Cvitkovic, Jeanne Kay Noel, Yves Paternot, and Patrice Herait in March 2007 and is headquartered in Luzern, Switzerland. | Director/Board Member | 01/12/2014 |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Director/Board Member | 01/01/2013 |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Director/Board Member | 01/03/2012 |
Fulcrum Ltd.
 Fulcrum Ltd. Miscellaneous Commercial ServicesCommercial Services Fulcrum Ltd. provides global fund administrative services. It provides services to the hedge fund and alternative investment management industries. The company has offices in New York, London, Canada, the Cayman Islands and India. Fulcrum was founded in 1995 and is headquartered in Hamilton, Bermuda. | Director/Board Member | 25/02/2010 |
Formation de Michael Carter
| The University of Sheffield | Doctorate Degree |
| UCL School of Pharmacy | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 19 |
|---|---|
Warner Chilcott Plc /Old/
 Warner Chilcott Plc /Old/ Pharmaceuticals: OtherHealth Technology Warner Chilcott Plc manufactures pharmaceutical products. It develops, markets, sells, and distributes prescription pharmaceutical products in the United States. Warner Chilcott was founded in 1992 and is headquartered in Larne, UK. | Health Technology |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Finance |
| CancerVax Corp. | Commercial Services |
GTx, Inc.
 GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Health Technology |
Santarus, Inc.
Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Health Technology |
Fulcrum Pharma Plc
 Fulcrum Pharma Plc Pharmaceuticals: OtherHealth Technology Fulcrum Pharma Plc provides drug development and regulatory expertise essential to progress a development program from research to product approval. The company was founded in 1999 and is headquartered in Hemel Hempstead, the United Kingdom. | Health Technology |
Metris Therapeutics Ltd.
 Metris Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Metris Therapeutics Ltd. develops pharmaceutical products. It is engaged in the research and development of medicines for the treatment of women's health disorders. The firm develops medicines to treat endometriosis, menstrual pain, and menopause symptoms. The company was founded by Stephen Smith in 1996 and is headquartered in Wokingham, UK. | Health Technology |
Micromet AG
 Micromet AG Pharmaceuticals: MajorHealth Technology Micromet AG developed, manufactured and marketed novel antibody derived therapeutics for the treatment and control of cancer, inflammatory and autoimmune diseases. It's goal was to commercialize products in these indication areas that have significant unmet medical needs. Founded in 1993, the company was headquartered in Munich, Germany. | Health Technology |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Health Technology |
Fulcrum Ltd.
Fulcrum Ltd. Miscellaneous Commercial ServicesCommercial Services Fulcrum Ltd. provides global fund administrative services. It provides services to the hedge fund and alternative investment management industries. The company has offices in New York, London, Canada, the Cayman Islands and India. Fulcrum was founded in 1995 and is headquartered in Hamilton, Bermuda. | Commercial Services |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Health Technology |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Finance |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Health Technology |
OncoEthix SA
OncoEthix SA Pharmaceuticals: MajorHealth Technology OncoEthix SA operates as a clinical stage biotechnology company which develops cancer drugs. Its products include OTX008, OTX015, and OTX009. The company was founded by Esteban Cvitkovic, Jeanne Kay Noel, Yves Paternot, and Patrice Herait in March 2007 and is headquartered in Luzern, Switzerland. | Health Technology |
Roche Products Ltd.
 Roche Products Ltd. Pharmaceuticals: MajorHealth Technology Roche Products Ltd. manufactures diagnostic, diabetes, and pharmaceutical products. The company was founded on December 14, 1908 and is headquartered in Welwyn Garden City, the United Kingdom. | Health Technology |
Zeneca Pharmaceuticals
 Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Zeneca Pharmaceuticals manufactures medicines. | Health Technology |
Atopix Therapeutics Ltd.
 Atopix Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Atopix Therapeutics Ltd. develops medicines to treat atopic dermatitis and severe asthma. The firm also assess the safety and pharmacokinetic profile of its back-up molecule ATX2417 in a phase I study. The company was incorporated on October 10, 2012 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Oncternal Oncology, Inc.
 Oncternal Oncology, Inc. Pharmaceuticals: MajorHealth Technology Oncternal Oncology, Inc. is a clinical-stage oncology company, which engages in the development of novel therapies for both rare and common cancers. The company was founded by Lauren Otsuki and Cam L. Garner and is headquartered in San Diego, CA. | Health Technology |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Health Technology |
